• Blog Post

Webinar: What Providers Need to Know: New Medication Options in Behavioral Health

Jul 6th, 2021

Behavioral Drug Approvals in 2020

The FDA’s Center for Drug Evaluation and Research approved 53 new drugs in 2020 alone, including several novel treatments for schizophrenia and other behavioral health conditions. What do providers need to know about these new medications?

Genoa Healthcare’s Chief Procurement Officer Stephanie Kornechuk, PharmD, recently hosted a webinar in which she addressed new behavioral drugs and their unique attributes. To learn more, watch the webinar, which:

  • Reviews 2020 behavioral drug approvals
  • Looks ahead at coming drug trends
  • Covers recent policy changes impacting treatment of opioid use disorder
  • Touches on recent COVID-19 vaccine developments

To learn more about how Genoa can help you and those you serve, contact us today.

Recent Posts


  • Pharmacy Openings
Announcing six new pharmacy openings!

We’re excited to announce the opening of six pharmacies last month. We welcome all new pharmacy staff to the team and are excited to partner with these organizations to serve...

  • Pharmacy Openings
Announcing seven new pharmacy openings!

We’re excited to announce the opening of seven pharmacies last month. We welcome all new pharmacy staff to the team and are excited to partner with these organizations to serve their...

  • Blog Post
Genoa Healthcare® Pharmacists’ Trusting Consumer Relationships Aid in Support for Long-Acting Injectable Treatments

Providing Support for Long-Acting Injectable Treatments When a consumer who had recently been discharged from the hospital came into their Genoa pharmacy to receive a long-acting injectable (LAI) treatment for...

  • News Releases
New medication options in behavioral health

FDA Approves 14 New Medications The FDA has approved 14 new medication and treatment options for the behavioral health space to date in 2022. The new medication and treatment options...